FARALLON CAPITAL MANAGEMENT LLC
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 909661
SAN FRANCISCO, CA
Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,271,617
-$7,446,954 QoQ
Shares Held
2,871,862
+3.6% QoQ
Ownership
9.88%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FARALLON CAPITAL MANAGEMENT LLC holds $5,160,870,541 across 65 Biotechnology names. ENTA ranks #16 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,604,796 | $1,323,066,411 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
9,365,463 | $695,479,282 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $669,174,692 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,111,010 | $562,331,218 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,338,098 | $302,839,719 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
9,675,000 | $267,997,500 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,134,696 | $241,509,805 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
5,684,000 | $192,289,720 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,271,617 | 2,871,862 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $43,718,571 | 2,772,262 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $25,403,476 | 2,122,262 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $16,044,300 | 2,122,262 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $11,714,886 | 2,122,262 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $12,122,506 | 2,108,262 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $21,841,594 | 2,108,262 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $27,172,150 | 2,095,000 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $36,578,700 | 2,095,000 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $19,055,250 | 2,025,000 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $20,943,750 | 1,875,000 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $40,125,000 | 1,875,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $62,682,000 | 1,550,000 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $72,106,000 | 1,550,000 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $80,398,500 | 1,550,000 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $73,268,500 | 1,550,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $110,329,000 | 1,550,000 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $117,690,932 | 1,573,829 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $113,335,950 | 1,995,000 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $87,799,950 | 1,995,000 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $98,393,400 | 1,995,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $74,727,500 | 1,775,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $81,259,500 | 1,775,000 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $87,867,500 | 1,750,000 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $90,002,500 | 1,750,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||